Latest in Finance

Niagen Bioscience acquires core nicotinamide riboside (NR) patent portfolio from Queen’s University Belfast

This acquisition establishes Niagen Bioscience as the sole owner of the most comprehensive and defensible intellectual property portfolio in the NAD+ industry

Find out more

dsm-firmenich completes €1.08bn share buyback ahead of schedule, plans 2026 share cancellation

The company has finalised its €1.08bn share repurchase programme earlier than expected, buying back nearly 13 million shares and plans to cancel over 12m shares in early 2026

 See more

VeCollal secures Seventure Partners investment for expansion of plant-based collagen

Corpowell’s VeCollal has raised new funding from Seventure Partners to accelerate global expansion of its biomimetic, plant-based collagen technology — unveiling clinical results showing a 20% reduction in visible cellulite and setting a new benchmark for sustainable, science-backed nutraceuticals

Lupin, TPG Capital & EQT in talks to acquire Vitabiotics in £1bn takeover

Indian pharmaceutical giant Lupin Pharma is reportedly in early-stage negotiations to acquire UK supplement leader Vitabiotics for around £1 billion to capitalise on booming demand in India’s rapidly expanding nutraceutical market

AKA Foods raises $17.2m to launch secure AI platform for food innovation in the Netherlands

The company has secured $17.2m seed funding to launch AKA Studio, a secure AI system that accelerates and optimises food product development by combining sensory research, R&D data and AI-driven insights

Hydrosol boosts investment in Asia with new Singapore UHT pilot plant and expanded technical support

Hydrosol's new UHT pilot plant in Singapore and expanded partnerships will support regional dairy, meat and convenience food manufacturers, helping them meet fast-growing consumer demand and local market trends

KÄÄPÄ Biotech raises €9m to scale Nordic functional mushroom production and global nutraceutical expansion

The Finland-based biotech has secured a strategic investment from PeakBridge VC and Zintinus VC to expand its Nordic cultivation facilities and accelerate global growth of its NordRelease functional mushroom ingredients

Zinzino acquires shares in Xion International Group for omega-3 and spirulina production

Zinino is aiming to form a joint venture to produce algae using bioreactors to meet the increased demand for the company's main product, BalanceOil+

ANJAC Health & Beauty Group acquires supplement provider PharmaLinea

The international industrial group has acquired a majority stake in PharmaLinea as well as its sister companies, ErgoPharma and Hermes Consilium

Perrigo to review its baby formula business

The consumer health company will initiate a strategic review of its infant formula business, including assessing higher-margin branded alternatives

Latest posts in Finance

ACG to invest $200 million in US hard-shell capsule manufacturing

ACG, the world’s most integrated provider of solid-dosage solutions, announces a $200m phased investment to establish its first empty capsule manufacturing operations in the United States

NSF acquires Cambium Analytica to expand food and supplement testing capabilities

The acquisition will strengthen NFS's analytical testing and product development services for the natural food, beverage and dietary supplement industries amid growing demand for health-focused innovation and regulatory compliance

MartinBauer acquires American Botanicals to expand US sourcing and strengthen global supply chain

The acquisition deepens MartinBauer’s US agricultural footprint and enhances its ability to deliver sustainable, high-quality botanicals worldwide

Asterix Foods raises $4.2m to deliver bioactive proteins at a fraction of precision fermentation’s cost

Israeli startup Asterix Foods has emerged from stealth with $4.2m in seed funding to scale its plant cell-based biomanufacturing platform, offering a low-CAPEX, modular alternative to precision fermentation for producing high-value, animal-free bioactive proteins

Menopause wellness brand Menoveda announces US launch

The ayurveda-based company enters a US market that is increasingly receptive to herbal and plant-based health solutions

Cosmos Health enters $1bn Kuwait nutraceutical market with exclusive Diyar United deal

Cosmos Health subsidiary SkyPharm has signed an exclusive distribution agreement with Diyar United to market its Sky Premium Life supplements in Kuwait, securing an initial order of more than 65,000 units

Omega-3 market to reach $7.76bn by 2030, driven by DHA and infant formula demand

MarketsandMarkets projects the global omega-3 market to grow at a CAGR of 12.2% through 2030, fuelled by rising awareness of cardiovascular and cognitive health benefits and increased use of DHA in infant formulas

BASF completes sale of food and health performance ingredients unit to Louis Dreyfus Company

The deal transfers 300 employees, a German production site and global application labs to LDC, expanding its plant-based ingredients portfolio whilst BASF sharpens its nutrition focus

Revyve secures €24m funding to boost egg-replacing yeast proteins

The investment will accelerate the company’s commercial rollout of functional yeast proteins designed to replace eggs and additives in mainstream food categories

Resbiotic raises $14.5m to expand science-backed Gut-X Axis health platform

The funding, including an $8m Series A, will be used to grow its clinically validated gut–x axis product portfolio, scale retail and ecommerce distribution and strengthen its B2B ingredient and formulations business

ADM surpasses 5 million regenerative agriculture acreage goal according to annual report

The company's third annual report details its work to support global food security through regenerative agricultural practices

Sponsor content

Global dietary supplements market set to reach $414.5bn by 2033 amid rising demand for personalised nutrition

A new Grand View Research report forecasts strong 8.9% CAGR growth for the supplements market through 2033, driven by wellness trends, personalised nutrition and...

ACG to invest $200 million in U.S. hard-shell capsule manufacturing

Dedicated facilities for gelatine and HPMC; 200+ jobs; operations targeted for early 2027; expands ACG’s 25-year U.S. presence

Heartland Food Products Group acquires SLIMFAST US brand

Heartland Food Products Group — manufacturer of SPLENDA BRAND low-calorie sweeteners, drink mixes, coffee and nutritional beverages — has acquired the SLIMFAST US...

Hope secures a home 3 days out from deadline

#HopeNeedsAHome campaign reaches milestone as global nutraceuticals industry leans in to secure sanctuary they can call home

Smartcore introduces AI-powered lead platform at Vitafoods Europe 2025

Smartcore Lead Insights enables data-driven sales strategies for the food and nutraceutical sector

Symrise delivers solid growth in Q1 and reaffirms outlook

Symrise AG had a healthy start into the 2025 fiscal year, with organic growth of 4.2% in  the first quarter. Reported sales rose 2.0% to €1,317 million (Q1 2024:...

TopGum takes strategic leap into North America with the acquisition of Island Abbey

New acquisition strengthens TopGum's position as a leading CDMO in gummy supplements

Dr. Anju Majeed welcomes Maldivian president at the India-Maldives Business Forum

Forum aims to strengthen bilateral ties and explore investment opportunities

Green Origins’ Organic Powders – Powering up from strength to strength

Green Origins has emerged as a leading figure in the global premium organic superfoods ingredient sector, with a strong emphasis on ethically sourced and high-quality...

dsm-firmenich completes the divestiture of its Jiangshan vitamin C plant in China

Financial details of the transaction were not disclosed

Syensqo invests in Bioeutectics, a start-up producing green solvents

The investment, made through Syensqo’s venture capital fund, will contribute to bring more sustainable products and processes to market

dsm-firmenich makes voluntary cash offer for DSM shares

DSM-Firmenich AG and DSM BV (DSM) announce that the remaining holders of DSM ordinary shares will have the opportunity to sell their DSM ordinary shares to dsm-firmenich...